Research Article

Atypical Femoral Fracture in Hypophosphatasia: A Systematic Review

Table 1

Characteristics of reported patients with hypophosphatasia and atypical femoral fracture.

Patient noStudyYearCountryAge, sexType of HPPAntiosteoporosis medication exposureUnilateral/BilateralOther fracture(s)ALPL variantsMedical treatment after AFF

1Anaraki et al. [15]2018US76FadultHPPAL (4 years), TPT (1 year), AL&ZA (3 years), ZA (3 years), DMAB (1 dose), TPT (1 year), followed by DMABUnilateralRight wrist, right metatarsal, right knee cap, left metatarsal and lumbar spine fracturesN/A
2Bhadada et al. [16]2020India47FadultHPPBilateralHeterozygous: c.311A > G (p.Asn104Ser)
3Buklemishev and Rodionova [17]2020Russia40MchildhoodHPPBilateralCompound heterozygous: c.182G > A (p.Gly61Glu), c.571G > A (p.Glu191lys)AA and alfacalcidol
4Chittimala et al. [18]2020US56MadultHPPBilateralN/A
5Coe et al. [19]1986US67FadultHPPBilateralN/A
6Coe et al. [19]1986US61FadultHPPUnilateralN/A
7Coe et al. [19]1986US66FadultHPPBilateralN/A
8Coe et al. [19]1986US69FadultHPPBilateralN/A
9Coe et al. [19]1986US45MadultHPPUnilateralN/A
10Doshi et al. [20]2009US53FadultHPPRISBilateralN/ATPT
11Fanous and Barb [21]2020US49FadultHPPUnilateralMultiple metatarsal stress fractures and a rib fractureHeterozygous: c.407G > A (p.Arg136His)AA
12Gagnon et al. [22]2010Australia53FadultHPPBilateralWrist and thoracic vertebral fracturesCompound heterozygous: c.526G > A (p.Ala176Thr), c.1268T > C (Val423Ala)TPT
13Klidaras et al. [23]2018US41FadultHPPBilateralRib and left tibial fracturesCompound heterozygous: c.526G > A (p.Ala176Thr), c1132G > C (p.Asp378His)AA
14Laurent et al. [24]2017France69FchildhoodHPPRIS (6 y) followed by DMABUnilateralWrist, metatarsal and tibial fracturesHeterozygous: c.361G > A (p.Val121Met)
15Lawrence et al. [25]2017UK55FadultHPPBilateralRight tibia and 4th and 5th metatarsal fracturesCompound heterozygous: c.526G > A p.(Ala176Thr), c.1171C > T p.(Arg391Cys)
16Lefever et al. [26]2020Belgium36FadultHPPBP and/or DMABN/AHomozygous: c.896T > C (p.Leu299Pro)
17Lefever et al. [26]2020Belgium69FadultHPPBP and/or DMABN/AHomozygous: c.896T > C (p.Leu299Pro)
18Maman et al. [27]2016France51MadultHPPBilateralMultiple metatarsal fracturesCompound heterozygous: T (p.Thr100Met), c.571G > A (p.Glu191Lys)
19Miller et al. [28]2017US61MadultHPPTPT (6 m)BilateralCompound heterozygous: A (p.Pro292Thr), c.1195G > A (p.Ala399Thr)AA
20Resch et al. [29]2016Austria25MadultHPPN/AN/A
21Righetti et al. [30]2017France67FadultHPPALBilateralFibular, ankle, and metatarsal fracturesHeterozygous: c.341C > T (p.Ala114Val)TPT
22Schalin-Jantti et al. [31]2010France56FadultHPPBilateralMetatarsal fracturesCompound heterozygous: c.1015G > A (p.Gly339Arg), c.571G > A (p.Glu191Lys)TPT
23Schalin-Jantti et al. [31]2010France64FadultHPPUnilateralCompound heterozygous: c.1015G > A (p.Gly339Arg), c.571G > A (p.Glu191Lys)TPT
24Schini and Eastell [32]2018UK48FadultHPPALBilateral2 metatarsal fractures
25Siami et al. [33]2022Iran30FadultHPPBilateral
26Sutton et al. [34]2012Canada55FadultHPPAL followed by ZABilateralLeft lower tibia stress periostosis, right 2nd metatarsal, left 2nd and 3rd metatarsal, right distal radius, right distal ulna and right talus avulsion fracturesHeterozygous: A (p.Arg71His)
27Warren et al. [35]2021Australia40FadultHPPDMABBilateralLeft navicular and 3rd and 5th metatarsal fracturesCompound heterozygous: A (p.Ala176Thr), c.881A > C (p.Asp294Ala)TPT
28Whyte et al. [36]2007US56FadultHPPUnilateralRight 4th and 5th metatarsal and left 5th metatarsal stress fracturesHeterozygous: T (p.Asp378Val)TPT

Abbreviations: AA: asfotase alfa; AL: alendronate; BP: bisphosphonate; DMAB: denosumab; F: female; M: male; N/A: not available; RIS: risedronate; TPT: teriparatide; UK: the United Kingdom; US: the United States; ZA: zoledronic acid.